Service and Content Disclaimer

Important Notice:

This site provides information and guidance only.

Nothing published here constitutes professional, legal, or health advice.

quirinovira.sbs offers general information and service descriptions for informational purposes only. No content or material on this site should be considered personalized advice. Engagement with our services is at your discretion, and all results may vary based on a range of factors.

General Notice

All materials, tools, and resources on this website are intended for reference and general informational use. While every effort is made to maintain accuracy, no guarantee is made as to completeness or current applicability. Business decisions should not rely solely on the information provided here; you should seek independent verification and, if needed, advice from professional service providers.

Limitation of Liability

The company is not liable for actions you take based on this website.

  • Use information at your own risk. We disclaim all responsibility for misinterpretation or misuse.
  • No claims or promises are made about achieving specific outcomes in ranking, traffic volume, or business results.
  • We do not accept liability for technical errors, interruptions, or data loss from using this site or services.
  • Third-party sites, content, or tools linked here are not under our control or guarantee.

Accuracy of Information

Efforts are made to keep information accurate and updated; however, errors, omissions, or outdated material may occur. We encourage verification before relying on advice or insights featured, especially regarding fast-changing SEO trends or regulatory matters.

All information is used at your own discretion and risk.

No Professional Advice Offered

No content here is a substitute for site-specific consulting, technical, or legal advice. Please consult qualified experts as needed.

External Links

Links, mentions, or resources to external sites are provided for convenience only and do not equal endorsement. Refer to those sites’ policies for specific claims, offers, or terms.

Results Disclaimer Statement

Results from SEO models, mapping, or strategy may vary for each business. Performance is influenced by competition, site condition, and changing search engine practices.

Results May Vary Notice

Variables such as industry, resources, and existing digital footprint impact actual outcomes. We do not guarantee any particular result for individual users or brands.

Financial and Regulatory Disclaimer

No financial, tax, or investment advice or guarantee is offered on this website.

  • Descriptions and case studies are examples, not predictions nor advice for individual users or companies.
  • Assess professional risk and seek independent consultation before acting on any strategic recommendations shared here.
  • No responsibility is taken for loss or adverse business impact from following suggestions shared through this site.

Jurisdiction and Compliance

This website is operated under South African law.

Legal disputes, claims, or regulatory issues are governed by local jurisdictions and should be addressed as required by law.

Compliance with all relevant provisions of South African and international law is our priority.

Users outside South Africa must ensure compliance with their national regulations before utilizing information on this website.

Indemnification

By using this site, you agree to indemnify us against liabilities resulting from misuse of the provided materials or non-compliance with these terms.

Severability

If any part of this disclaimer is found unenforceable, the remaining sections stay in force.

Changes

quirinovira.sbs may revise this disclaimer at any time. Material updates will be posted on this page.

Contact

Questions about this disclaimer can be sent to us via the contact form or email below.

Email Address: content@quirinovira.sbs

Phone: +27425624133

Address: Pharos House, 18 The Boulevard, Westville, Durban 3629 South Africa

Effective Date: March 13, 2026

Last Updated: March 13, 2026